you are here:

Glenmark Pharma Ltd.

BSE: 532296 | NSE: GLENMARK |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE935A01035 | SECTOR: Pharmaceuticals

BSE Live

Nov 27, 16:00
471.20 2.45 (0.52%)
Volume
AVERAGE VOLUME
5-Day
126,938
10-Day
102,186
30-Day
110,622
83,915
  • Prev. Close

    468.75

  • Open Price

    471.00

  • Bid Price (Qty.)

    471.20 (364)

  • Offer Price (Qty.)

    475.00 (20)

NSE Live

Nov 27, 15:59
471.40 2.50 (0.53%)
Volume
AVERAGE VOLUME
5-Day
2,331,184
10-Day
1,791,223
30-Day
2,604,252
2,060,073
  • Prev. Close

    468.90

  • Open Price

    471.00

  • Bid Price (Qty.)

    471.40 (9292)

  • Offer Price (Qty.)

    0.00 (0)

Financials

2019 2018 2017 2016 2015
Cash Flow of Glenmark Pharma (in Rs. Cr.) Mar 20 Mar 19 Mar 18 Mar 17 Mar 16  
  12 mths 12 mths 12 mths 12 mths 12 mths  
Net Profit/Loss Before Extraordinary Items And Tax 1,534.64 1,818.18 1,218.83 2,552.90 1,746.53  
Net CashFlow From Operating Activities 1,579.12 2,489.58 1,123.72 877.72 354.75  
Net Cash Used In Investing Activities -1,607.38 -2,255.61 -1,137.12 -2,580.29 -1,545.60  
Net Cash Used From Financing Activities -139.42 -155.11 -61.58 1,879.38 1,222.55  
Foreign Exchange Gains / Losses -0.02 0.08 0.00 0.00 0.00  
Adjustments On Amalgamation Merger Demerger Others 0.00 0.00 0.15 -0.17 0.51  
Net Inc/Dec In Cash And Cash Equivalents -167.71 78.95 -74.84 176.64 32.23  
Cash And Cash Equivalents Begin of Year 255.00 176.05 250.88 74.24 42.02  
Cash And Cash Equivalents End Of Year 87.29 255.00 176.05 250.88 74.24  
Source : Dion Global Solutions Limited